X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2010-12-29 | RXII | Cytrx Corp | 10% | S - Sale | $2.20 | -2,593,881 | 0 | -100% | -$5,706,538 | ||||||
2010-12-22 | RXII | Cytrx Corp | 10% | S - Sale | $2.65 | -500,000 | 2,593,881 | -16% | -$1,325,000 | ||||||
2010-06-30 | RXII | Cytrx Corp | 10% | S - Sale | $2.55 | -2,000,000 | 3,093,881 | -39% | -$5,100,000 | ||||||
2010-03-26 | RXII | Cytrx Corp | 10% | S - Sale | $5.70 | -675,000 | 5,093,881 | -12% | -$3,847,500 | ||||||
2009-09-23 | RXII | Cytrx Corp | 10% | S - Sale | $2.50 | -500,000 | 5,768,881 | -8% | -$1,250,000 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |